This is a demo store. No orders will be fulfilled.

Peficitinib (ASP015K) - 98%, high purity , CAS No.944118-01-8, Inhibitor of Janus kinase 1;Inhibitor of Janus kinase 2;Inhibitor of Janus kinase 3;Inhibitor of tyrosine kinase 2

In stock
Item Number
P413804
Grouped product items
SKU Size
Availability
Price Qty
P413804-5mg
5mg
3
$249.90
P413804-10mg
10mg
3
$408.90
P413804-25mg
25mg
2
$717.90
P413804-50mg
50mg
2
$1,232.90
P413804-100mg
100mg
2
$2,059.90

JAK2 Selective Inhibitors

Basic Description

Synonyms 4-(((1R,2s,3S,5s,7s)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2,3-b)pyridine-5-carboxamide | 1H-Pyrrolo(2,3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13,7)dec-2-yl)amino)-, stereoisomer | GTPL8315 | AMY42225 | 9T6 | PEFICITINIB [INN] | JNJ-54
Specifications & Purity Moligand™, ≥98%
Biochemical and Physiological Mechanisms Peficitinib (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type INHIBITOR
Mechanism of action Inhibitor of Janus kinase 1;Inhibitor of Janus kinase 2;Inhibitor of Janus kinase 3;Inhibitor of tyrosine kinase 2
Product Description

Information

Peficitinib (ASP015K, JNJ-54781532) is an orally bioavailableJAKinhibitor. Phase 3.


Targets

JAK


In vitro

ASP015K suppresses the IL-2-induced proliferation of human T cells with greater potency than EPO-induced proliferation of human erythroleukemia cells. In human whole blood, ASP015K inhibits STAT5 phosphorylation (pSTAT5).


In vivo

In the rat AIA model, ASP015K (p.o.) significantly decreases paw swelling and ankle bone destruction score.

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Pyrrolopyridines
Subclass Not available
Intermediate Tree Nodes Not available
Direct Parent Pyrrolopyridines
Alternative Parents Pyridinecarboxamides  Secondary alkylarylamines  Aminopyridines and derivatives  Vinylogous amides  Tertiary alcohols  Pyrroles  Heteroaromatic compounds  Primary carboxylic acid amides  Cyclic alcohols and derivatives  Amino acids and derivatives  Azacyclic compounds  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Pyrrolopyridine - Pyridine carboxylic acid or derivatives - Pyridinecarboxamide - Secondary aliphatic/aromatic amine - Aminopyridine - Pyridine - Heteroaromatic compound - Vinylogous amide - Tertiary alcohol - Pyrrole - Cyclic alcohol - Primary carboxylic acid amide - Carboxamide group - Amino acid or derivatives - Azacycle - Secondary amine - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Amine - Alcohol - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as pyrrolopyridines. These are compounds containing a pyrrolopyridine moiety, which consists of a pyrrole ring fused to a pyridine. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Pyridine is a 6-membered ring consisting of five carbon atoms and one nitrogen center.
External Descriptors Not available

Associated Targets(Human)

TYK2 Tclin Non-receptor tyrosine-protein kinase TYK2 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
JAK3 Tclin Tyrosine-protein kinase JAK3 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
JAK1 Tclin Tyrosine-protein kinase JAK1 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
JAK2 Tclin Tyrosine-protein kinase JAK2 (2 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[[(1S,3R)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
INCHI InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14?,18?
InChIKey DREIJXJRTLTGJC-JQCLMNFQSA-N
Smiles C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O
Isomeric SMILES C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O
PubChem CID 57928403
Molecular Weight 326.39

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot Number Certificate Type Date Item
F2313934 Certificate of Analysis Mar 04, 2025 P413804
F23131303 Certificate of Analysis Mar 04, 2025 P413804
F2313927 Certificate of Analysis Mar 04, 2025 P413804
F2313949 Certificate of Analysis Mar 04, 2025 P413804
F2313931 Certificate of Analysis Mar 04, 2025 P413804

Chemical and Physical Properties

Solubility Solubility (25°C) In vitro DMSO: 65 mg/mL (199.14 mM); Water: Insoluble; Ethanol: Insoluble;
Molecular Weight 326.400 g/mol
XLogP3 1.900
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 3
Exact Mass 326.174 Da
Monoisotopic Mass 326.174 Da
Topological Polar Surface Area 104.000 Ų
Heavy Atom Count 24
Formal Charge 0
Complexity 525.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 2
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.